Prevalence of Hepatitis B and/or Hepatitis C in 1 Haemodialysis Patients in Benghazi Renal Units
Ramadan M. Bujazia Ali O. El-Fitouri, A. Fatah Y. Zaied, Hanan. M.T. Bugaigis. Yasmina. A Al-Sharaki, Mohamed. H. Khafifi
واصفات البياناتعرض سجل المادة الكامل
201 patients with end stage renal disease (ESRD) on maintenance haemodialysis (H.D) program, from 7th October and Hawari hospital renal units were studied for the prevalence of hepatitis B surface antigen (HbsAg) and or hepatitis C virus antibody (HCV Ab) by using the ELISA method (Hepanostika HbsAg unform II Organon Teknika) which qualitatively detects HbsAg subtypes ad and ay, and (UBI HCV EIA 4.0, United biochemical Inc. USA). It consists of synthetic peptides which correspond to the highly antigenic segments of HCV core regions (NS3, NS4, NS5) to detect HCV antibody. The study showed positive HbsAg results in 20 patients and positive HCV Ab in 133 patients and dual infections (HbsAg and HCV ab) in 23 patients with prevalence rates of 10%, 66.2% and 11.4% respectively. So the total prevalence rates for HbsAg and HCV antibody are 21% and 78% respectively. This study recommends more urgent preventive medical measures to be taken to decrease the prevalence rates of hepatitis B and or C viruses in HID units.
- مجلة العلوم الطبية